Biologics - Newer Treatment Option for Rheumatoid Arthritis: A Review

Authors

  • MA Rahim
  • KN Uddin
  • S Zaman
  • AKMS Ahmed
  • JU Ahmed
  • MD Hossain
  • AKM Musa
  • T Samad
  • HF Haque
  • P Dewan
  • MS Kabir
  • MR Rahman

DOI:

https://doi.org/10.3329/birdem.v2i1.12361

Keywords:

rheumatoid arthritis, biologics, new drugs

Abstract

Better understanding of pathogenesis of Rheumatoid Arthritis (RA) has enabled researchers to introduce newer agents for treatment of RA. These new agents, known as biological response modifiers or biologics, singly or commonly, in combination with other conventional disease modifying anti-rheumatic drugs, seem to be better in patients acceptability, tolerance, clinical and radiological response. These drugs are responsible for significant immune-suppression, may result in sepsis and reactivation of per se latent infections. Some agents are suspected to be related to cancer development. The higher cost and significant adverse effects are important concerns in clinical use of biological agents in RA.

DOI: http://dx.doi.org/10.3329/birdem.v2i1.12361

Birdem Med J 2012; 2(1) 44-51

Downloads

Download data is not yet available.
Abstract
854

Published

2012-10-24

How to Cite

Rahim, M., Uddin, K., Zaman, S., Ahmed, A., Ahmed, J., Hossain, M., Musa, A., Samad, T., Haque, H., Dewan, P., Kabir, M., & Rahman, M. (2012). Biologics - Newer Treatment Option for Rheumatoid Arthritis: A Review. BIRDEM Medical Journal, 2(1), 44–51. https://doi.org/10.3329/birdem.v2i1.12361

Issue

Section

Review Articles